Search
Enter keywords, a title or a report id number below.
Your Search for 'OTC Pharmaceuticals - Netherlands - a snapshot (2011)' returned 11 results - Page 1 of 1
Sort by
Sorted by
Rank
Top-Bottom
-
Netherlands Pharmaceuticals and Healthcare Report Q4 2011
Business Monitor International, Aug 2011 , Pages: 78Netherlands Pharmaceuticals and Healthcare Report Q4 2011 Business Monitor International's Netherlands Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443for Prescription Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011 and ... -
Netherlands Pharmaceuticals and Healthcare Report Q2 2012
Business Monitor International, Feb 2012 , Pages: 80: While the Netherlands is a low risk market from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe countries ... -
Netherlands Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Nov 2010 , Pages: 77Netherlands Pharmaceuticals and Healthcare Report Q1 2011 Netherlands Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ... -
Netherlands Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 81, especially during the patent cliff years. Headline Expenditure Projections - Pharmaceuticals: EUR5.90bn (US$7.83bn) in 2010 to EUR5.94bn (US$8.50bn) in 2011; +0.7% growth in local currency terms and +8.6 ... -
Netherlands Pharmaceuticals and Healthcare Report Q2 2010
Business Monitor International, Feb 2010 , Pages: 78sales will reach EUR6.11bn (US$8.85bn), before declining to EUR6.08bn (US$8.57bn) as medicines start to lose intellectual property protection in 2011. By 2014, pharmaceutical expenditure in the Netherlands ... -
Hungary Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 100achieved. Headline Expenditure Projections: - Pharmaceuticals: HUF678bn (US$3.27bn) in 2010 to HUF696bn (US$3.74bn) in 2011; +2.6% in local currency terms and +14.3% in US dollar terms. Forecast ... -
Switzerland Pharmaceuticals and Healthcare Report Q3 2012
Business Monitor International, Jul 2012 , Pages: 85maintain suitable levels of sales and profits. Headline Expenditure Projections - Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% decline in local currency terms ... -
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012 , Pages: 85Projections - Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to CHF5.73bn (US$6.71bn) in 2011; -2.6% growth in local currency terms and +19.08% in US dollar terms. - Healthcare: CHF59.54bn (US$57.09bn) in ... -
United Kingdom Pharmaceuticals and Healthcare Report Q3 2009
Business Monitor International, Jul 2009 , Pages: 99author forecasts a decline in the growth of the country’s drug market as a result of the upcoming patent cliff, a period – starting in 2009, peaking in 2011, and continuing through to 2013 – when almost ... -
India Pharmaceuticals and Healthcare Report Q1 2009
Business Monitor International, Feb 2009 , Pages: 125continues to expand, both locally and abroad, although it has not all been plain sailing. In late 2008, Indian Zydus Cadila – a unit of Cadila Healthcare – purchased Italy-based Etna Biotech from Dutch ...
Results:
First - Prev -
1 -
Next - Last
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
